Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins

JAMA Dermatology - Tập 154 Số 12 - Trang 1401 - 2018
Caroline C. Kim1, Elizabeth Berry2,3, Michael A. Marchetti4, Susan M. Swetter5,6, Geoffrey F.S. Lim7, Douglas Grossman8,9, Clara Curiel‐Lewandrowski10, Emily Y. Chu11, Michael E. Ming11, Kathleen Zhu12, Meera Brahmbhatt2,13, Vijay Shankar Balakrishnan2,3, Michael J. Davis2,3, Zachary Wolner4, Nathaniel H. Fleming5,6, Laura K. Ferris7, John D. Nguyen14, Oleksandr Trofymenko10, Yuan Liu2, Shuo Chen2,3
1Pigmented Lesion Clinic and Cutaneous Oncology Program, Department of Dermatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts
2Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia
3Division of Dermatology, Atlanta Veterans Administration Medical Center, Decatur, Georgia
4Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
5Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California
6Pigmented Lesion and Melanoma Program, Department of Dermatology, Stanford University Medical Center, Palo Alto, California
7Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania
8Department of Dermatology, Huntsman Cancer Institute, University of Utah, Salt Lake City
9Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City
10Pigmented Lesion Clinic and Multidisciplinary Cutaneous Oncology Program, Division of Dermatology, Department of Medicine, University of Arizona, Tucson
11Pigmented Lesion Clinic, Department of Dermatology, University of Pennsylvania, Philadelphia
12University of Massachusetts Medical School, Worcester
13Morehouse School of Medicine, Atlanta, Georgia
14University of Utah, Salt Lake City

Tóm tắt

Từ khóa


Tài liệu tham khảo

Duffy, 2012, Clinical decision making based on histopathologic grading and margin status of dysplastic nevi., Arch Dermatol, 148, 259, 10.1001/archdermatol.2011.2045

Tong, 2016, Degree of clinical concern and dysplasia affect biopsy technique and management of dysplastic nevi with positive biopsy margins: Results from a survey of New England dermatologists., J Am Acad Dermatol, 74, 389, 10.1016/j.jaad.2015.09.055

Nelson, 2018, Management strategies of academic pigmented lesion clinic directors in the United States., J Am Acad Dermatol, 79, 367, 10.1016/j.jaad.2017.12.069

Kim, 2015, Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement., JAMA Dermatol, 151, 212, 10.1001/jamadermatol.2014.2694

Fleming, 2016, Reexamining the threshold for reexcision of histologically transected dysplastic nevi., JAMA Dermatol, 152, 1327, 10.1001/jamadermatol.2016.2869

Blum, 2014, Recurrent melanocytic nevi and melanomas in dermoscopy: results of a multicenter study of the International Dermoscopy Society., JAMA Dermatol, 150, 138, 10.1001/jamadermatol.2013.6908

Gutman, 2017, The Digital Slide Archive: a software platform for management, integration, and analysis of histology for cancer research., Cancer Res, 77, e75, 10.1158/0008-5472.CAN-17-0629

Arumi-Uria, 2003, Grading of atypia in nevi: correlation with melanoma risk., Mod Pathol, 16, 764, 10.1097/01.MP.0000082394.91761.E5

Kmetz, 2009, The role of observation in the management of atypical nevi., South Med J, 102, 45, 10.1097/SMJ.0b013e3181904289

Goodson, 2010, Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi., J Am Acad Dermatol, 62, 591, 10.1016/j.jaad.2009.06.080

Hocker, 2013, Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border., J Am Acad Dermatol, 68, 545, 10.1016/j.jaad.2012.09.031

Hiscox, 2017, Recurrence of moderately dysplastic nevi with positive histologic margins., J Am Acad Dermatol, 76, 527, 10.1016/j.jaad.2016.09.009

Gandini, 2005, Meta-analysis of risk factors for cutaneous melanoma: I, common and atypical naevi., Eur J Cancer, 41, 28, 10.1016/j.ejca.2004.10.015

Duncan, 1993, Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study., J Invest Dermatol, 100, 318S, 10.1038/jid.1993.55

Duray, 1992, An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions., J Am Acad Dermatol, 27, 741, 10.1016/0190-9622(92)70248-E

Nobre, 2013, Analysis of interobserver reproducibility in grading histological patterns of dysplastic nevi., An Bras Dermatol, 88, 23, 10.1590/S0365-05962013000100002

Piepkorn, 1994, A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi., J Am Acad Dermatol, 30, 707, 10.1016/S0190-9622(08)81499-5

Nickleach